|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.960 CNY | +2.36% |
|
+17.04% | -5.86% |
| 04-28 | Beijing Science Sun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-24 | India stocks, rupee, swaps, call at 3:30 p.m. IST | RE |
| Market Cap | 4.8B 707M 618M 568M 529M 1B 67.3B 1.02B 6.82B 2.65B 33.08B 2.65B 2.6B 114B | P/E 2024 |
-50.1x | P/E 2025 | 353x |
|---|---|---|---|---|---|
| Enterprise Value | 3.26B 480M 419M 385M 359M 681M 45.66B 692M 4.63B 1.8B 22.45B 1.8B 1.76B 77.35B | EV / Sales 2024 |
4.33x | EV / Sales 2025 | 8.78x |
| Free-Float |
42.82% | Yield 2024 * |
-
| Yield 2025 | 2.84% |
| 1 day | +2.36% | ||
| 1 week | +17.04% | ||
| Current month | +4.73% | ||
| 1 month | +11.53% | ||
| 3 months | -11.70% | ||
| 6 months | -10.83% | ||
| Current year | -5.86% |
| 1 week | 9.24 |  | 10.2 |
| 1 month | 7.77 | | 10.2 |
| Current year | 7.77 | | 12.9 |
| 1 year | 7.77 | | 17.49 |
| 3 years | 5.73 | | 17.49 |
| 5 years | 5.73 | | 18.75 |
| 10 years | 5.73 | | 28.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 62 | 2001-07-04 |
Dong Na Liang
DFI | Director of Finance/CFO | 45 | 2024-01-25 |
Li Ma
DFI | Director of Finance/CFO | 57 | 2006-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Wang
BRD | Director/Board Member | 48 | 2009-02-28 |
Biao Ma
CHM | Chairman | 62 | 2001-07-04 |
Li Ma
BRD | Director/Board Member | 57 | 2005-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.36% | +17.04% | -32.20% | -2.92% | 707M | |
| +1.86% | +0.48% | +55.50% | +160.66% | 1,082B | |
| +3.57% | +3.29% | +68.60% | +61.56% | 633B | |
| +3.99% | +3.05% | +37.93% | +89.70% | 461B | |
| -1.31% | +1.37% | +31.00% | +23.05% | 338B | |
| -0.65% | +0.38% | +40.46% | +38.96% | 299B | |
| -0.28% | +0.84% | +30.38% | +45.16% | 291B | |
| -0.14% | +3.62% | -26.04% | -39.70% | 222B | |
| +3.55% | +4.41% | +25.45% | +65.64% | 202B | |
| +4.21% | +2.65% | +17.47% | +69.95% | 163B | |
| Average | +1.71% | +4.31% | +24.85% | +51.21% | 369.31B | |
| Weighted average by Cap. | +1.82% | +5.43% | +41.87% | +81.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 416M 61.36M 53.64M 49.29M 45.95M 87.15M 5.84B 88.47M 592M 230M 2.87B 230M 225M 9.9B | 405M 59.63M 52.12M 47.9M 44.65M 84.69M 5.68B 85.97M 575M 224M 2.79B 224M 219M 9.62B |
| Net income | -68.85M -10.14M -8.87M -8.15M -7.6M -14.41M -966M -14.63M -97.84M -38.03M -475M -38.08M -37.26M -1.64B | 14.57M 2.15M 1.88M 1.72M 1.61M 3.05M 204M 3.1M 20.7M 8.05M 100M 8.06M 7.88M 346M |
| Net Debt | -1.57B -232M -202M -186M -173M -329M -22.05B -334M -2.23B -868M -10.84B -869M -850M -37.34B | -1.54B -227M -199M -183M -170M -323M -21.63B -328M -2.19B -852M -10.63B -853M -835M -36.64B |
Employees
489
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | CN¥9.960 | +2.36% | 16,402,805 |
| 26-07-02 | CN¥9.730 | -1.32% | 18,418,200 |
| 26-07-01 | CN¥9.860 | +3.68% | 22,495,400 |
| 26-06-30 | CN¥9.510 | -1.65% | 19,801,091 |
| 26-06-29 | CN¥9.670 | +13.63% | 27,527,038 |
- Stock Market
- Stocks
- 300485 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
